Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-10-14
2000-09-05
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514564, 514567, 562451, 562453, 562455, 562456, 562458, C07C22934, A61K 31195
Patent
active
061143863
ABSTRACT:
A sialidase inhibitor of the shown formula I: ##STR1## where dashed lines d.sub.1 and d.sub.2, X.sub.1, R.sub.1, R.sub.2, R.sub.6, R.sub.3, R.sub.4 and R.sub.5 are as described in the specification; or an analog, pharmaceutically acceptable salt, or derivative of the inhibitor, with the proviso that the inhibitor is not HANBA GBA or Neu5Ac2en. The inhibitor in a composition with a pharmaceutically acceptable carrier. Methods of making a pharmaceutical composition of an acceptable carrier and the inhibitor. Methods of inhibiting sialidase and methods of treating and preventing bacterial or trypanosomal infection using the inhibitor.
REFERENCES:
patent: 5360817 (1994-11-01), von Izstein et al.
patent: 5453533 (1995-09-01), Luo et al.
Ries et al, J. Med. Chem., vol. 36, p. 4040-4051, 1993.
Singh, et al., "Structure-based Inhibitors of Influenza Virus Sialidase Benzoic Acid Lead with Novel Interaction," J. Med. Chem., 38:3217-3225 (1995).
Preston et al., J. Chem. Soc., p. 500-504 (1942).
Aymard-Henry, M., et al., "Influenzavirus neuraminidase and neuraminidase-inhibition test procedures", Bull. Wld Hlth Org. 45:119-124 (1971).
Briselden, A. M., Moncla, B. J., Stevens, C. E. & Hillier, S. L. (1992). Sialidases (-neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. Journal of Clinical Microbiology 30(3), 663-6.
Cacalano, G., Kays, M., Saiman, L. & Prince, A. (1992). Production of the Pseudomonas aeruginosa neuraminidase is increased under hypersmolar conditions and is regulated by genes involved in alginate expression. Journal of clinical Investigation 89(6), 1866-74.
Childs, W. D. & Gibbons, R. J. (1990). Selective modulation of bacterial attachment to oral epithelial cells by enzyme activities associated with poor oral hygiene. Journal of Periodontal Research 25(3), 172-8.
Costello, A. H., Cisar, J.O., Kolenbrander, P.E. & Gabriel, O. (1979). Neuraminidase-dependent hamagglutination of human erythrocytes by human strains of Actinomyces viscosus and Actinomyces naeslundii. Infection & Immunity 26(2), 563-72.
Crennell, S.J., et al., "Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase)", Proc. Natl. Acad. Sci. USA 90:9852-9856 (1993).
Crennell, S., et al., "Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain", Structure 2:535-544 (1994).
Drzeniek, R., "Viral Bacterial Neuraminidases", Current Topics In Microbiology & Immunology, 59:35-74 (1972).
Flashner, M., et al., "The Interaction of Substrate-Related Ketals with Bacterial and Viral Neuraminidases", Archives of Biochemistry and Biophysics 221:188-196 (1983).
Cross, G.A.M. & Tackle, G.B., "The Surface Trans-Sialidase Family of Trypanosoma Cruzi", Annu. Rev. Microbiol. 47:385-411 (1993).
Guzman, C. A., Plate, M. & Pruzzo, C. (1990). Role of neuraminidase-dependent adherence in Bacteroides fragilis attachment to human epithelial cells. FEMS Microbiology Letters71, 187-92.
Hall, F.B. & Joiner, K.A., "Developmentally-Regulated Virulence Factors of Trypansoma cruzi and Their Relationship to Evasion of Host Defences" J. Euk. Microbiol. 40(2):207-213 (1993).
Hoffler, U., Gloor, M. & von Nicolai, H. (1981). Neuraminidase production by Propionibacterium acnes-strains isolated from patients with acne vulgaris, seborrheic eczema and healthy subjects. Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene-250(1-2), 122-6.
Holzer, C.T., et al., "Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2, 3-didehydro-N-acetylneuraminic acid modified at the C-4 position", Glycoconjugate Journal 10:40-44 (1993).
Hoyer, L.L., et al., "Purification and Properties of Cloned Salmonella typhimurium LT2 Sialidase with Virus-Typical Kinetic Preference for Sialyl .alpha.2.fwdarw.3", J. Biochem. 110:462-467 (1991).
Kleineidam, R.G., et al., "4-Methylumbelliferyl-.alpha.-Glycosides od Partially Oacetylated N-Acetylneuraminic Acids as Substrates of Bacterial and Viral Sialidases", Biol. Chem. Hoppe-Seyler 371:715-719 (1990).
LaMarco, K. K., Diven, W. F. & Glew, R. H. (1986). Experimental alteration of chinchilla middle ear mucosae by bacterial neuraminidase. Annals of Otology, Rhinology & Laryngology 95(3 Pt 1), 304-8.
Liljemark, W. F., Bloomquist, C. G., Fenner, L. J., Antonelli, P.J. & Coulter, M.C. (1989). Effect of neuraminidase on the adherence to salivary pellicle of Streptococcus sanguis and Streptococcus mitis. Caries Research 23:141-145.
Marchand, N.W., Kishore, G.S. & Carubelli, R. (1978). Neuraminidase activity in the blood and liver of arthritic rats. Experimental & Molecular Pathology 29(3), 273-80.
Meindl, P., et al., "Inhibition of Neuraminidase Activity by Derivatives of 2-Deoxy-2, 3-dehydro-N-acetylneuraminic Acid", Biology 58:457-463 (1974).
Miller, C.A., et al., Mechanism of Arthrobacter sialophilus Neuraminidase: The Binding of Substrates and Transition-State Analogs, Biochemical and Biophysical Research Communications, 83:1479-1487 (1978).
Milligan, T. W., Baker, C. J., Straus, D. C. & Mattingly, S. J. (1978). Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infection & Immunity 21(3), 738-46.
Mosquera, J. & Rodriguez-Iturbe, B. (1984). Extracellular neuraminidase production of streptococci associated with acute nephritis. Clinical Nephrology 21(1), 21-8.
Nakato, H., Shinomiya, K. & Mikawa, H. (1986). Possible role of neuraminidase in the pathogenesis of arteritis and thrombocytopenia induced in rats by Erysipelothrix rhusiopathiae. Pathology, Research & Practice 181(3), 311-9.
Pereira, M.E.A., et al., "The Trypanosoma cruzi Neuraminidase Contains Sequences Similar to Bacterial Neuraminidases, YWTD Repeats of the Low Density Lipoprotein Receptor, and Type III Modules of Fibronectin", J. Ex. Med. 174:179-191 (1991).
Preston et al., J. Chem. Soc. 500-04 (1942).
Schenkman, R.P.F., "Mammalian Cell Sialic Acid Enhances Invasion by Trypanosoma cruzi", Infection and Immunity 61:898-902 (1993).
Scudder, P., et al., "Enzymatic Characterization of .beta.-D-Galactoside .alpha.2, 3-transSialidse from Trypanosoma cruzi" The Journal of Biological Chemistry 268:9886-9891 (1993).
Seger, R., Joller, P., Baerlocher, K., Kenny, A., Dulake, C., Leumann, E., Spierig, M. & Hitzig, W. H. (1980). Hemolytic-uremic syndrome associated with neuraminidase-producing microorganisms: treatment by exchange transfusion. Helvetica Paediatrica Acta 35(4), 359-67.
Takle, G.B., & Cross, G.A.M., "An 85-kilodalton surface antigen gene family of Trypanosoma cruzi encodes polypeptides homologous to bacterial neuraminidases", Molecular and Biochemical Parasitology 48:185-198 (1991).
Vandekerckhove, F., "Substrate specificity of the Trypanosoma cruzi trans-sialidase", Glycobiology 2:541-548 (1992).
Warner, T.G., et al., "Photolabelling of Salmonella typhimurium LT2 sialidase,", Biochem. J. 285:957-964 (1992).
Luo Ming
White Clinton L.
Dentz Bernard
University of Alabama
LandOfFree
Inhibitors of bacterial sialidase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of bacterial sialidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of bacterial sialidase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212623